Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Delev

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Scientific Reports|May 17, 2025
A self-supervised multimodal deep learning approach to differentiate post-radiotherapy progression from pseudoprogression in glioblastomaAhmed Gomaa, Yixing Huang, Pluvio Stephan, et al.
Nature Communications|June 13, 2019
Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastomaDieter Henrik Heiland, Vidhya M Ravi, Simon P Behringer, et al.
Journal of Neurophysiology|February 27, 2025
Comprehensive analysis of human dendritic spine morphology and densityKerstin D Schünemann, Roxanne M Hattingh, Matthijs B Verhoog, et al.
Journal of Neuro-Oncology|May 1, 2025
Reirradiation for recurrent glioblastoma: the significance of the residual tumor volumeSina Mansoorian, Manuel Schmidt, Thomas Weissmann, et al.
Nature Communications|February 18, 2022
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10Vidhya M Ravi, Nicolas Neidert, Paulina Will, et al.
NPJ Precision Oncology|November 27, 2025
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation studyJulius M Kernbach, Urte Schroeder, Karlijn Hakvoort, et al.
Trials|January 20, 2022
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trialThomas Zeyen, Anna-Laura Potthoff, Robert Nemeth, et al.
Cancer Cell|June 14, 2022
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastomaVidhya M Ravi, Paulina Will, Jan Kueckelhaus, et al.
Cancers|July 27, 2022
Two Decades of Brain Tumour Imaging with O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich ExperienceAlexander Heinzel, Daniela Dedic, Norbert Galldiks, et al.
Brain & Spine|March 21, 2024
Functional hemispheric disconnection procedures for chronic epilepsy: history, indications, techniques, complications and current practice in Europe. A consensus statement on behalf of the EANS functional neurosurgery sectionOlaf E M G Schijns, Daniel Delev, Marec von Lehe, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Scientific Reports|May 17, 2025
A self-supervised multimodal deep learning approach to differentiate post-radiotherapy progression from pseudoprogression in glioblastomaAhmed Gomaa, Yixing Huang, Pluvio Stephan, et al.
Nature Communications|June 13, 2019
Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastomaDieter Henrik Heiland, Vidhya M Ravi, Simon P Behringer, et al.
Journal of Neurophysiology|February 27, 2025
Comprehensive analysis of human dendritic spine morphology and densityKerstin D Schünemann, Roxanne M Hattingh, Matthijs B Verhoog, et al.
Journal of Neuro-Oncology|May 1, 2025
Reirradiation for recurrent glioblastoma: the significance of the residual tumor volumeSina Mansoorian, Manuel Schmidt, Thomas Weissmann, et al.
Nature Communications|February 18, 2022
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10Vidhya M Ravi, Nicolas Neidert, Paulina Will, et al.
NPJ Precision Oncology|November 27, 2025
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation studyJulius M Kernbach, Urte Schroeder, Karlijn Hakvoort, et al.
Trials|January 20, 2022
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trialThomas Zeyen, Anna-Laura Potthoff, Robert Nemeth, et al.
Cancer Cell|June 14, 2022
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastomaVidhya M Ravi, Paulina Will, Jan Kueckelhaus, et al.
Cancers|July 27, 2022
Two Decades of Brain Tumour Imaging with O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich ExperienceAlexander Heinzel, Daniela Dedic, Norbert Galldiks, et al.
Brain & Spine|March 21, 2024
Functional hemispheric disconnection procedures for chronic epilepsy: history, indications, techniques, complications and current practice in Europe. A consensus statement on behalf of the EANS functional neurosurgery sectionOlaf E M G Schijns, Daniel Delev, Marec von Lehe, et al.
Pageof 10